2024. JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation. Biomolecules and Biomedicine. 24, 4 (Feb. 2024), 897–911. DOI:https://doi.org/10.17305/bb.2024.9979.